This statistic depicts the top biotech and conventional pharmaceutical product launches globally in 2018 and their projected revenues for 2022. AbbVie's probably in 2018 to be-launched product Elagolix is expected to garner some 1.2 billion U.S. dollars in 2022.
Projection of top 2018 pharma and biotech launches by revenue 2022
Top biotech and pharma product launches in 2018 and revenue forecast for 2022
(in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Italy: number of biotech drugs marketed 2016-2017, by type
- Global pharmaceutical product launches by therapy area 2004-2013
- Projection of top 10 global pharmaceutical products by revenue 2019
- Top drugs based on projected 2019 year-on-year sales increase
- Italy: number of R&D employees of biotech pharma companies 2014-2017
- Italy: turnover of biotech drugs 2014-2017
- Italy: value of investments in R&D of biotech pharma companies 2014-2017
- Italy: number of biotech companies in the pharma sector 2014-2017
- Members of EFPIA's pharmaceutical exports and imports 1990-2018
- Count of first-time medtech approvals granted by FDA 2006-2017
- Italy: production value of pharmaceutical companies 2015-2017
- Global pharmaceutical gross value added by product type 2012
- Share of global pharmaceutical gross value added by product type 2012
- Global jet lag therapy market size by 2016 and 2023
- Austria: medicament mixtures not in dosage export value 2012-2018
- Industry revenue of »manufacture of basic pharmaceutical products« in Spain 2011-2023
- Poland: pharmaceutical goods import value 2012-2018
- Industry revenue of »manufacture of optical and photographic equipment« in Hungary 2011-20...
Further related statistics
EP Vantage. (December 26, 2017). Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 10, 2019, from https://www.statista.com/statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
EP Vantage. "Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)." Chart. December 26, 2017. Statista. Accessed December 10, 2019. https://www.statista.com/statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
EP Vantage. (2017). Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 10, 2019. https://www.statista.com/statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
EP Vantage. "Top Biotech and Pharma Product Launches in 2018 and Revenue Forecast for 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 26 Dec 2017, https://www.statista.com/statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/
EP Vantage, Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/407953/revenue-forecast-of-top-pharma-and-biotech-launches-worldwide/ (last visited December 10, 2019)